Latest Regulatory News

Tissue Repair Limited reports steady progress in its Phase 3 clinical trials for TR987® despite patient recruitment hurdles, while TR Pro+® sales surge and new distribution deals pave the way for international growth.

Clarity Pharmaceuticals has bolstered its cash reserves to approximately $288 million following a $203 million institutional placement, while reporting significant clinical progress across multiple copper-based radiopharmaceutical trials targeting prostate cancer and neuroendocrine tumours.

Delorean Corporation has marked significant progress in Q4 FY2025, advancing its renewable gas infrastructure and securing crucial regulatory support that could unlock new revenue streams.

Audio Pixels Holdings reports a delay in its MEMS wafer production due to a key fabrication step requiring revision, while its shares remain suspended on the ASX. The company signals the need for additional funding within six months to sustain its R&D efforts.

Carbonxt Group Limited advances its Kentucky activated carbon facility with increased ownership and imminent kiln commissioning, while securing $1 million in convertible notes to support growth. The company reports steady revenue and strong market positioning amid tightening US EPA PFAS regulations.

Cambium Bio has cleared key regulatory hurdles for its lead dry eye disease treatment, Elate Ocular, and strengthened its balance sheet with a $2.12 million placement to support upcoming Phase 3 trials.

Savannah Goldfields is advancing plans to resume gold production at its Georgetown processing plant and Big Reef mine, capitalizing on gold prices above A$5000 per ounce. The company also unveiled new exploration targets and key executive appointments to drive growth.

Bayan Mining and Minerals Limited has announced a loyalty options offer, granting shareholders one option for every four shares held, exercisable at $0.075 until late 2027. This move aims to incentivize shareholder engagement while potentially raising capital.

Mineral Commodities Ltd faces ongoing delays in the sale of its Skaland Graphite asset amid partial payments and defaults, while advancing negotiations to fully acquire the Munglinup Graphite Project. Operational challenges and financial pressures underscore a pivotal phase for the company’s battery minerals strategy.

Domino’s Pizza Enterprises has explained the late filing of a director interest notice as an administrative oversight, reaffirming its compliance procedures amid ASX scrutiny.

Northern Minerals reports strong progress on its Browns Range Heavy Rare Earths Project with key regulatory approvals, promising exploration results, and near-completion of its Definitive Feasibility Study amid tightening global supply.

Northern Minerals Limited reported a $5.1 million cash outflow from operations in the June quarter but bolstered its balance sheet with a $42.4 million equity raise, ending the period with $24.3 million in cash.